Large scale discovery and validation of brain cell type enhancers for viral targeting and circuit manipulation

用于病毒靶向和回路操纵的脑细胞类型增强剂的大规模发现和验证

• 批准号: 10327151
• 负责人: Yarui Diao
• 金额: $ 393.13万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-09-23 至 2023-09-22
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10327151
• 关键词: Large; scale; discovery; validation; brain

Abstract – No change from original application Brain functions emerge from highly nuanced spatiotemporal dynamics of neural circuit computation mediated by diverse and precisely interconnected neuron types. Specific and systematic experimental access to these cell types are prerequisites to deciphering brain circuit organization and function, but this has been a prohibitive bottleneck in neuroscience. Although powerful, current genetic approaches in mammals are mostly restricted to germline engineering in the mouse and have fundamental limitations in time, cost, scale, versatility and clinical application. What is urgently needed is the ability to identify and manipulate cell types in a way that is: 1) specific (to bona fide types defined by anatomical and physiological properties), 2) comprehensive (to many cell types), 3) fast (days instead of months to years), 4) inexpensive, and 5) across mammalian species. We propose to develop a paradigm-shifting platform that will enable rapid and comprehensive access for brain cell types across mammalian species by leveraging fundamental epigenomic and gene regulatory basis of cell types - the transcriptional enhancers. We will establish a cellular resolution and scalable pipeline for identifying cell type enhancers in the mouse brain that combines 1) chromatin landscape analysis (ATAC-seq) in genetic driver-defined neuronal subpopulations, 2) innovative AAV- and sequencing-based massively parallel reporter assays in these subpopulations, 3) high-throughput validation using a novel method of integrated spatial transcriptomics and sequencing-based projection mapping, and 4) high-resolution whole brain morphological imaging. We aim for comprehensive coverage of neuron types of the cerebral cortex, including both glutamatergic pyramidal neurons and GABAergic interneurons, though our strategy and tools will be general to other brain regions and species. The Huang lab has systematically generated combinatorial genetic driver lines targeting major cortical neuron subpopulations and has discovered the transcriptional basis of cortical neuron types. Bing Ren is a leader in enhancer biology and has pioneered the technical advances in cell type and single cell chromatin analysis, including computational approaches. Tony Zador invented MAPseq, BARseq and other sequencing-based methods that enable high throughput, cellular resolution mapping of neuronal connectivity. Pavel Osten has pioneered developing high-resolution and high-throughput whole brain imaging pipelines with associated computational analysis. Together, our knowledge and expertise constitute a synergistic team focusing on an excellent experimental system for the systematic screening, discovery and validation of cell type enhancers and for generating cell census datasets that contribute to the BICCN goals. Our approach is grounded in fundamental genetic principles and mechanisms and has the potential to transform the scale and rate of discovery across neuroscience and biomedical fields.

摘要-与原始应用程序没有变化